CV Sciences Inc (OTCMKTS: CVSI) has been performing remarkably as a company focusing on hemp-derived cannabidiol (CBD) products, and today it highlights its plans for the future. First, it seeks to develop and commercialize its CBD-based pharmaceutical, an undertaking it hopes will enable it to treat persons struggling with nicotine addiction.
The collaboration and its essence
It partners with researchers from the University of California to publish a preclinical study that has adequately demonstrated the effectiveness and efficacy of chronic CBD treatment in eliminating nicotine dependence among the affected persons. The focus on dealing with the withdrawal symptoms has been one of the most critical lines of thought in the whole undertaking.
The study also turned to animal models, and the results are out. Through animal models, scientists have come to recognize the effects of CBD in minimizing the craving for alcohol and cocaine. In addition, they discovered the effects of the substance in the modulation of the nicotinic receptor function as well.
Researchers opened up on their findings of the study involving rats, in which case these rodents were treated with CBD. The rats in question had been dependent on nicotine, and there was the need to focus on the withdrawal symptoms.
Scientists administered the treatment that prevented the animal from showing withdrawal symptoms such as weight gain and increased pain sensitivity during the short- and long-term nicotine restriction phase.
The Chief Executive Officer of CV Sciences, Joseph Dowling, seems pretty excited about the outcome of the research conducted together with UC San Diego.
Dowling opined, “This study marked a key milestone in CV Sciences’ smokeless tobacco addiction treatment R&D efforts and further extends our potential product development opportunities to commercialize the world’s first and only FDA-approved treatment for smokeless tobacco addiction to address a huge unmet medical need and global health issue.”
The Green Organic Dutchman Holdings (OTC: TGODF) Releases an Update on its Canadian Securities Exchange Listing
Post Views: 4 The Green Organic Dutchman Holdings (OTC: TGODF) is a top producer of organically-grown, premium certified marijuana, and it...
Next Green Wave Holdings Inc (OTCMKTS: NXGWF) Announces the Resignation of One of Its Directors
Post Views: 55 Next Green Wave Holdings Inc (OTCMKTS: NXGWF) recently announced that a Director had resigned from this position. The...
AFC Gamma Inc (NASDAQ: AFCG) Increases Quarterly Dividend by 13.2% per Share, and the Group Expands its Senior Secured Credit Facility with Devi Holdings, Inc. by $30 Million
Post Views: 26 AFC Gamma Inc (NASDAQ: AFCG) recently announced a dividend for the quarter ending September 30, 2021. The...
TerrAscend Corp (OTCMKTS: TRSSF) Acquisition of Gage Cannabis Receives Pre-Qualification Approval
Post Views: 53 TerrAscend Corp (OTCMKTS: TRSSF) is a leading cannabis operator based in North America that recently announced it had...
Jushi Holdings Inc (OTCMKTS: JUSHF) Opens 15th Store in Pennsylvania, Acquires Nature’s Remedy, and Announced Launch of Flower Brands
Post Views: 2 Jushi Holdings Inc (OTCMKTS: JUSHF), through its subsidiary, Franklin Bioscience – SE LLC. BEYOND / HELLO™ Colwyn...
FinCanna Capital Corp (OTCMKTS: FNNZF) Set to launch its “Big Fish” Cannabis-Based Edibles Brand
Post Views: 3 FinCanna Capital Corp (OTCMKTS: FNNZF) is an investment corporation for the United States licensed cannabis market that recently...